Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC
Status:
Unknown status
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of sorafenib in combination with low
dose cisplatin /fluorouracil hepatic arterial infusion chemotherapy in patients with advanced
hepatocellular carcinoma.